Page 18 - GTM-3-3
P. 18

Global Translational Medicine                                   Influence of estrogen on RV mitochondria in PH



            inhibitor  (U0126)  prevented  and  reversed  PH  in  male   focus on examining the expressions of these mitochondrial
            hypoxic rats, reducing both pulmonary pressure and RV   genes in both animal models of PH and PAH patients
            hypertrophy.  All these studies suggested that ERK1/2   in both sexes at different RV stages (compensated and
                      97
            may be a therapeutic target in PAH.                decompensated)  through   transcriptomic/proteomic
                                                               analysis and/or mass spectrometry and their molecular
            6.6. Summary                                       mechanisms in  in vitro and  in vivo preclinical studies
            The expression of these above-mentioned genes in RV   before the development of therapies for RV in PAH.
            in PAH is summarized in  Table 2 and the associated
            molecular pathway is presented in Figure 2. Due to limited   Acknowledgments
            data on these E2-  and mitochondria-related genes and   None.
            proteins and data mainly obtained from males (Table 2),
            the role of each gene or protein in altering RV function   Funding
            in different sexes at different RV stages (compensated and   This study was supported in part by the Engineering and
            decompensated) in PAH is still unclear. More studies are   Physical Sciences Research Council (EPSRC) Student
            required to examine the mechanistic pathways in Figure 2   Excellence Award (SEA) Studentship (C.C.), Faculty
            and their importance to RV function in PAH.
                                                               Start-Up Fund from the University of Strathclyde (L.T.),
            7. Conclusions                                     RSE Re-Boot (COVID-19 Impact) Research Grants
                                                               (L.T.), and the Academy of Medical Sciences Springboard
            PAH is a sex dimorphism condition, with females being at   Award (L.T.).
            a higher risk than males. The mortality of PAH relies on the
            status of the RV and has been associated with alterations in   Conflict of interest
            mitochondrial functions. E2 can regulate mitochondrial   The authors declare no conflicts of interest.
            biogenesis activity, influence mtDNA replication and
            repair, as well as influence the balance of mitochondrial   Author contributions
            fusion/fission proteins. Restoring mitochondrial function
            is expected to improve RV function in PAH.  However,   Conceptualization: Chelbi Coyle, Lian Tian
                                                100
            limited studies exist on these mitochondrial genes and the   Writing – original draft: Chelbi Coyle
            associated molecular pathways as discussed in this review.   Writing – review & editing: All authors
            Future studies are needed to determine the expressions of   Ethics approval and consent to participate
            these mitochondrial genes at different RV stages in PAH.
            Transcriptomic and proteomic analysis are being used for   Not applicable.
            profiling  including  mitochondria-  and  E2-related  genes
            and  proteins. 101,102   Mass  spectrometry  can  be  used  to   Consent for publication
            reveal the levels of E2 in the RV. 75,102  Further studies are   Not applicable.
            also required to understand the exact mitochondrial genes,
            proteins, and signaling pathways by which E2 targets and   Availability of data
            the E2-mitochondria interaction in RV in PAH of both   Not applicable.
            sexes in  in  vitro studies,  in  vivo preclinical studies, and
            clinical investigation  to identify druggable targets and   References
            develop promising therapeutics. Finally, PAH patients are
            currently receiving the same treatments regardless of sex,   1.   Humbert M, Guignabert C, Bonnet S, et al. Pathology and
                                                                  pathobiology of pulmonary hypertension: State of the art
            even though studies have shown that male and female PAH   and research perspectives. Eur Respir J. 2019;53(1): 1801887.
            patients respond to treatments differently.  Therefore,
                                               103
            personalized treatments based on sex could be taken into      doi: 10.1183/13993003.01887-2018
            consideration in the future.                       2.   Simonneau  G, Montani D, Celermajer DS,  et al.
              Mitochondria play an important role in RV function,   Haemodynamic  definitions  and  updated  clinical
            but the molecular mechanisms for sex-dependent        classification of pulmonary hypertension.  Eur Respir J.
                                                                  2019;53(1):1801913.
            mitochondrial function and the role of estrogen
            (especially E2) in RV in PAH are not well understood. In      doi: 10.1183/13993003.01913-2018
            addition, understanding the roles of E2 and its targeting   3.   Prins KW, Thenappan T. World Health Organization
            mitochondrial genes in RV function shall provide insight   Group  I pulmonary hypertension: Epidemiology and
            into therapeutics for RV in PAH. Future studies should   pathophysiology. Cardiol Clin. 2016;34(3):363-374.


            Volume 3 Issue 3 (2024)                         8                               doi: 10.36922/gtm.2494
   13   14   15   16   17   18   19   20   21   22   23